
Experience
TriSalus Life Sciences Completes Merger With MedTech Acquisition Corporation
August 16, 2023
Cooley advised TriSalus Life Sciences, an oncology company with a focus on treatments for patients with liver and pancreatic tumors, on its merger with MedTech Acquisition Corporation.
Related contacts
Related Practices & Industries
Sprout Social Acquires Tagger Media
August 4, 2023
Cooley advised Sprout Social, a social media management software company, on its $140 million acquisition of Tagger Media, a top influencer marketing platform, and a concurrent $100 million secured debt facility, which will be partially used to fund the acquisition.
Related contacts
Related Practices & Industries
Justin Bieber to Sell Music Rights to Hipgnosis Songs for $200 Million
February 2, 2023
Cooley advised Justin Bieber in a $200 million deal to sell his music rights to Blackstone-backed Hipgnosis Songs Capital.
Related contacts
M33 Growth Inks Series of Investments
August 9, 2022
Cooley advised M33 Growth, a venture and growth-stage investment firm, on a series of strategic investments in:
- Operix (formerly IFS Core), a provider of software solutions for specialty contractors that allow for more efficient management of field operations personnel and processes through seamless integrations with core accounting platforms.
- PerformLine, a provider of a cloud-based, multichannel sales and marketing compliance platform for the banking, mortgage, insurance and financial services industries to monitor enterprise communication channels for regulatory and brand compliance and improve reporting and issue remediation workflows.
- Leading2Lean, a provider of a cloud-based digital workflow platform for discrete manufacturers that enables factories to implement more efficient production and maintenance processes.
- Yapi, a provider of a communication and patient engagement platform for dental offices that streamlines front office and marketing workflows, automates appointment reminders and digitizes paper-based forms such as patient consents.
Related contacts
Related Practices & Industries
Sixth Street Invests in Blueprint Medicines
July 7, 2022
Cooley advised global investment firm Sixth Street on its strategic investment in Blueprint Medicines, a global precision therapy company that invents life-changing therapies for people with cancer and blood disorders. Lawyers Mischi a Marca, Matt Browne, Matt Scarano, Addison Pierce, Matt Kong and Nick Neuteufel led the Cooley team advising Sixth Street.